These results, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two help the notion of focusing on ACKR3 as a novel solution to modulate the opioid system, which could open new therapeutic avenues for opioid-related Conditi